These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cathepsin D activity and protein degradation products in organs and blood during experimental declamping shock. Głowiński S; Gacko M; Głowiński J; Worowska A; Maksymczuk M; Worowski K Rocz Akad Med Bialymst; 1995; 40(1):180-6. PubMed ID: 8528989 [TBL] [Abstract][Full Text] [Related]
43. Changes in the magnesium content of tissues following myocardial damage in rats. Abraham AS; Bar-On E; Eylath U Med Biol; 1981 Apr; 59(2):99-102. PubMed ID: 7311631 [TBL] [Abstract][Full Text] [Related]
44. [Behavior of serum proteins, glycoproteins and lipoproteins in myocardial infarction]. Stazka Z Pol Tyg Lek; 1965 Apr; 20(15):511-4. PubMed ID: 5837703 [No Abstract] [Full Text] [Related]
45. [Amino acid metabolic disorder in kidney failure (a review of the literature)]. Terekhov NT; Levchenko IV; Lipkan GN Vrach Delo; 1982 Nov; (11):12-6. PubMed ID: 6818768 [No Abstract] [Full Text] [Related]
46. Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, and location of expression. Leor J; Quiñones MJ; Patterson M; Kedes L; Kloner RA J Mol Cell Cardiol; 1996 Oct; 28(10):2057-67. PubMed ID: 8930802 [TBL] [Abstract][Full Text] [Related]
47. [The protein spectrum and its clinical value. 1. Total serum protein concentration]. Fateh-Moghadam A Fortschr Med; 1978 Nov; 96(41):2084-6. PubMed ID: 700595 [No Abstract] [Full Text] [Related]
50. [Substrate provision of the cardiac muscle in myocardial infarct: selectivity of using metabolites, dependence on time factors]. Gil'miiarova FN; Golenishchev VIu; Radomskaia VM Biull Eksp Biol Med; 1995 Jun; 119(6):621-4. PubMed ID: 8589388 [No Abstract] [Full Text] [Related]
51. [Lincomycin binding by serum proteins and tissues]. Fateeva LI Antibiotiki; 1983 Jun; 28(6):453-6. PubMed ID: 6881956 [No Abstract] [Full Text] [Related]
52. Myocardial zinc and other cation composition in experimental myocardial infarction. Lindeman RD; Yunice AA; Baxter DJ; Miller LR J Lab Clin Med; 1971 Nov; 78(5):804. PubMed ID: 5128841 [No Abstract] [Full Text] [Related]
53. [Symposium on hypoproteinemia. (6) Hypoproteinemia in cancer]. Wada T Nihon Naika Gakkai Zasshi; 1967 Nov; 56(11):1260-4. PubMed ID: 5627549 [No Abstract] [Full Text] [Related]
55. Peculiarities of microciirculation and reparative processes in the development of experimental myocardiail infarction. Trubetskoy AV; Lysenko LT; Zhdanov VS Biochem Exp Biol; 1977; 13(3):283-9. PubMed ID: 16296010 [No Abstract] [Full Text] [Related]
56. Collagen metabolism in patients with myocardial infarction. Kucharz E; Drózdz M; Cerazy B; Jendryczko A Cor Vasa; 1982; 24(5):339-44. PubMed ID: 7172687 [TBL] [Abstract][Full Text] [Related]
57. [Effect of sex steroids on the histamine content of the myocardium in dogs]. Pereira GR; Maciel RE; Ramalho AC; Menegatto G Arq Bras Cardiol; 1984 Jun; 42(6):387-92. PubMed ID: 6517727 [No Abstract] [Full Text] [Related]
58. [Cathepsin D activity and myocardial protein degradation in controlled cardiac arrest during operations with extracorporeal circulation]. Głowiński S; Worowski K Kardiol Pol; 1980; 23(5):425-30. PubMed ID: 7392367 [No Abstract] [Full Text] [Related]
59. [The anabolic and androgenic effect of methandrostenolone in experiments with male rats]. Iodaev NA; Pokrovskiĭ BV Vopr Med Khim; 1966; 12(5):527-32. PubMed ID: 6000175 [No Abstract] [Full Text] [Related]
60. [Symposium on homeostasis in disease states. 1. Serum proteins]. Anzai T Nihon Naika Gakkai Zasshi; 1970 Nov; 59(11):1156-61. PubMed ID: 5530672 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]